Revised forecast
Fiscal year ending March 2027 · Six months and full yearThe bar length represents the relative magnitude of change, based on the item that changed the most in this document.
Fiscal year ended March 2026, consolidated: total extraordinary losses of ¥0 million (loss on disposal of fixed assets ¥0 million, loss on sale of investment securities ¥0 million). Standalone: ¥443 million recorded as provision for business losses of affiliated companies.
| Item | Details |
|---|---|
| Net Sales | Not disclosed → Cumulative second quarter: 63,000; full year: 150,000（Cumulative second quarter: 2.2%; full year: 3.0%） |
| Operating profit | Not disclosed → Cumulative second quarter: 1,700; full year: 5,900（Cumulative second quarter: 1.4%; full year: 10.7%） |
| Ordinary income | Not disclosed → Cumulative second quarter: 1,800; full year: 6,000（Cumulative second quarter: -0.4%; full year: 3.7%） |
| Profit attributable to owners of the parent | Not disclosed → Cumulative second quarter: 1,200; full year: 4,000（Cumulative second quarter: 0.2%; full year: 0.9%） |
| Net income per share | Not disclosed → Cumulative second quarter: 53.82; full year: 179.41 |
| Fiscal Period Covered | Fiscal year ending March 2027 |
| Period Covered | Six months and full year |
| Previous-period results | Fiscal year ended March 2026: net sales ¥145,614 million, operating income ¥5,332 million, ordinary income ¥5,784 million, net income attributable to owners of the parent ¥3,966 million |
| Details and amount of extraordinary loss | Fiscal year ended March 2026, consolidated: total extraordinary losses of ¥0 million (loss on disposal of fixed assets ¥0 million, loss on sale of investment securities ¥0 million). Standalone: ¥443 million recorded as provision for business losses of affiliated companies. |
| Dividend forecast revision | For the fiscal year ending March 2027, the company forecasts an interim dividend of ¥50, a year-end dividend of ¥50, and an annual dividend of ¥100. There is no statement that the dividend forecast was revised in conjunction with the revision to the earnings forecast. |
| Consolidated / non-consolidated | Consolidated (individual results also provided for reference) |
Items this document does not state (2)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.In the fiscal year ended March 2026, the module business within the Information and Communications and Devices segment and the business serving the medical sector remained firm, while the number of large-scale projects in the Building Equipment and Infrastructure businesses increased. For the fiscal year ending March 2027, the company expects demand for capital investment related to automation, decarbonization, AI and DX to grow.